Health
2 min read
Study Adds to Evidence Linking Injectafer Iron Medication to Severely Low Phosphorus
In January, I announced Pogust Millrood’s filing of the nation’s first lawsuit against the big pharma companies responsible for Injectafer, an IV medication meant to reverse iron deficiency and increase anemic patients’ quality of life. A number of patients are instead reporting severe hypophosphatemia (HPP),…